Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
2021; Taylor & Francis; Volume: 62; Issue: 12 Linguagem: Inglês
10.1080/10428194.2021.1941926
ISSN1042-8194
AutoresBeata Ostrowska, Agnieszka Szymczyk, Magdalena Olszewska‐Szopa, Joanna Romejko‐Jarosińska, Katarzyna Domańska‐Czyż, Anna Dąbrowska‐Iwanicka, Waldemar Tomczak, Sebastian Rybski, Marek Hus, Tomasz Wróbel, Jan Walewski,
Tópico(s)Chronic Lymphocytic Leukemia Research
Resumo(2021). Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation. Leukemia & Lymphoma: Vol. 62, No. 12, pp. 3031-3034.
Referência(s)